GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
I felt this may drp but rebound. However, in light of the BoD performance recently what is going to create the bounce? I don't see a forgone conclusion that new or former investors putting money in at 122p when it gets there (and it will so I wish they would help it over with) gi en the fact all they may experience is more of the same.
Scandalous what has happened here.
The way the BoD have totally NOT supported the SP is beyond belief.
As before seeing 150p support any further down and it's obvious they will gap fill to 122p.
The BoD have allowed them to do this and bo doubt thu will.
Absolutely no denying Covid is still here. Cases numbers picking up and deaths likely to remain at this née level for sometime, yet the governement seem to want to treat it as if its over. Everyone back to work but you must have jabs too - apparently. It makes no sense.
Anyway, the jist of the post is to really say I made the mistake of focusing g on the story, the cases and the hospitalisations for too long. It's clearly apparent that the SP here at the start was linked to this data but now it is not andnthis is proved by how the Omicron wave didn't impact heavily and positively on our bottom line.
It's all about the next step here. We await the new financial year by the sounds of it to find out.
If you were about to buy projects off a company for billions and you could buy shares in the company and re coup 'x' to 'y' times that invest because you were triggering the dividend because you were buying the company...its would make sense to buy as much EUA stock as possible.
HarChis,
The hope of good news was built into the expectation of results inline or better and a forward statement that lit the blue touch paper - in a good way.
Unfortunately, results were inline at best and a reiteration of 50% less revenue next year. As for the forward statement , well it seemed clear to me it's more or less as we are. On one hand covid is still at the forefront of the revenue generation and we will not move into big and exciting markets like Oncology or transplantation but instead use our portfolio and react to new emerging diseases immediately.
DA also made clear we will get more colour on this in April with the full year results. Therefore and by deduction I don't see anything coming till them, as he stated. Till then it's 2 to 3 months of not alot and the SP is rooted in a downtrend.
This may not be what agreeable with some but better opportunities may come along before April to buy.
I would say the biggest positive is the cash at the bank so reasonably should it go below this - probably not unless the signs are we won't be making money but spending it in the future. The issue today was - NO FUTURE PLANS FOR REVENUE GENERATION.
The question serious investors will ask is, has the company built out to wide and will this be a drag on cash at the bank going forwards.
Agree bakky I believe a dip to 122p would be a technical temporary.
We will have to see how how it reacts to upper at 170p
Wilson.
These are price targets if the outside world changes then the targets change.
You can clearly see we are in the grips of a down trend as I pointed out when I said I sold out between 300- 330p.
It's certainly not a backtrack, I did what I said at the time for the direction I could see. I did try to make clear my observations even when unfortunately negative. People can make their own minds up to sell buy or hold but O e been clear re the down trend for sometime.
Support sits firmly at 170p next, I would say its almost certain we will hit that.
The question really after that is
1. Rebound
2 Fill the gap to 122p
I have absolutely no idea what will happen after hitting 170p (should it do so). I guess that's the chance we all take.
Good luck all, fornthe time being I feel thebbest place is on the sidelineds especially observing. Feels like between 200-300p is fair value atm. Maybe a bag to be made if they do go for the gap fill? Maybe all is not lost for supporters of the share.
Lower low posted today could signal the downtrend may still continue.
Next support 170p, gap fill to 122p seems unthinkable but who knows on AIM.
So results looked in line cash at the bank too which was a positive for me as I was worried is may have ended up a little lower. Any hope of increased revs due to Omicron seem to be wishful thinking.
Covid outlook only painted slightly better but still unclear as the future of Covid remains unclear still.
Biggest note is the future guidance. I personally was expecting alot more, focus on turning us into a player in a certain field but overall it looks like we will be market lead to responding to infectious diseases.
All indexes now going blue.
Panic over.....back over 26p tomorrow.
Just don't get this company strategy one bit.
Support at 250/220 then 170/180.
It will be interesting to see how long it starts NCYT to tamp up and build sustainable and business supportable long term revenues in their new strategy.
I feel people may have over looked this might be something that come about overnight.
Right now the business is heading towards a critical sl juncture. Covid revenues decreasing, wage bill, R & D, restructuring costs, marketing costs all going up against time taken to build up supporting revenues.
My worry is they will eat away at money earned in Covid without before they can execute the new strategy.
I feel sitting on your hands on the sidelines maybe the best course of action at the moment.
*Amount even!
200p plus
175-200p
150-175p
125-150p
100-125p